Vinod Chandran

15.1k total citations · 1 hit paper
278 papers, 7.9k citations indexed

About

Vinod Chandran is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Vinod Chandran has authored 278 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Rheumatology, 193 papers in Immunology and 102 papers in Hematology. Recurrent topics in Vinod Chandran's work include Spondyloarthritis Studies and Treatments (199 papers), Psoriasis: Treatment and Pathogenesis (177 papers) and Autoimmune and Inflammatory Disorders Research (101 papers). Vinod Chandran is often cited by papers focused on Spondyloarthritis Studies and Treatments (199 papers), Psoriasis: Treatment and Pathogenesis (177 papers) and Autoimmune and Inflammatory Disorders Research (101 papers). Vinod Chandran collaborates with scholars based in Canada, United States and United Kingdom. Vinod Chandran's co-authors include Dafna D. Gladman, Lihi Eder, Richard J. Cook, Arane Thavaneswaran, Cheryl F. Rosen, S. P. Raychaudhuri, Catherine T. Schentag, Proton Rahman, Fawnda Pellett and Sutha Shanmugarajah and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vinod Chandran

259 papers receiving 7.7k citations

Hit Papers

Psoriatic arthritis 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Psoriatic arthritis
    2021 190 citations Oliver FitzGerald, Vinod Chandran et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinod Chandran Canada 49 5.7k 5.5k 2.8k 752 623 278 7.9k
Daniel O. Clegg United States 35 3.9k 0.7× 2.2k 0.4× 1.4k 0.5× 303 0.4× 342 0.5× 99 5.4k
Eduardo Collantes‐Estévez Spain 43 4.1k 0.7× 2.5k 0.4× 1.3k 0.5× 103 0.1× 913 1.5× 294 6.1k
Masako Hara Japan 43 2.3k 0.4× 1.3k 0.2× 577 0.2× 276 0.4× 916 1.5× 183 5.1k
Susanna Proudman Australia 40 2.1k 0.4× 861 0.2× 515 0.2× 585 0.8× 648 1.0× 251 5.7k
Ingiäld Hafström Sweden 39 2.7k 0.5× 863 0.2× 731 0.3× 55 0.1× 846 1.4× 111 4.8k
Wayne Gulliver Canada 33 819 0.1× 1.5k 0.3× 211 0.1× 1.8k 2.4× 359 0.6× 101 3.8k
Christina Ellervik Denmark 39 531 0.1× 529 0.1× 947 0.3× 665 0.9× 839 1.3× 184 4.8k
Vladimı́r Tesař Czechia 48 2.9k 0.5× 1.8k 0.3× 875 0.3× 45 0.1× 1.6k 2.6× 385 11.4k
Marc A. Riedl United States 33 1.3k 0.2× 876 0.2× 848 0.3× 164 0.2× 695 1.1× 171 4.4k
Sarfaraz Hasni United States 25 1.0k 0.2× 1.6k 0.3× 203 0.1× 102 0.1× 764 1.2× 67 3.4k

Countries citing papers authored by Vinod Chandran

Since Specialization
Citations

This map shows the geographic impact of Vinod Chandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinod Chandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinod Chandran more than expected).

Fields of papers citing papers by Vinod Chandran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinod Chandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinod Chandran. The network helps show where Vinod Chandran may publish in the future.

Co-authorship network of co-authors of Vinod Chandran

This figure shows the co-authorship network connecting the top 25 collaborators of Vinod Chandran. A scholar is included among the top collaborators of Vinod Chandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinod Chandran. Vinod Chandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eder, Lihi, Xianwei Li, Vinod Chandran, et al.. (2025). Association of Higher Levels of High‐Sensitivity C‐Reactive Protein With Future Development of Psoriatic Arthritis in Psoriasis: A Prospective Cohort Study. Arthritis Care & Research. 77(11). 1288–1292.
2.
Hay, M. Cameron, Wilson Liao, Christine A. Lindsay, et al.. (2025). Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis. Lara D. Veeken. 64(8). 4641–4649. 3 indexed citations
3.
Dang, Stuti, Xianwei Li, Vincent Piguet, et al.. (2025). Sex differences in serum proteomic profiles in psoriatic arthritis. Lara D. Veeken. 64(11). 5911–5920.
4.
Chandran, Vinod, Wilson Liao, & Kurt de Vlam. (2024). Biomarkers in Psoriasis and Psoriatic Arthritis: Where Are We Now?. The Journal of Rheumatology. 51(Suppl 2). 74–76. 1 indexed citations
5.
6.
Fine, Noah, et al.. (2024). Characterisation of myeloid cells in circulation and synovial fluid of patients with psoriatic arthritis. RMD Open. 10(4). e004457–e004457. 3 indexed citations
7.
8.
Chandran, Vinod, Louis Bessette, Carter Thorne, et al.. (2024). Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and Therapy. 11(2). 443–455. 3 indexed citations
9.
Chandran, Vinod, et al.. (2024). Challenges in the Metabolomics-Based Biomarker Validation Pipeline. Metabolites. 14(4). 200–200. 15 indexed citations
10.
Chandran, Vinod, Vladislav A. Malkov, Kaori Ito, et al.. (2023). Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial. RMD Open. 9(4). e003550–e003550. 5 indexed citations
11.
Chandran, Vinod, et al.. (2023). Autoantibodies in psoriatic disease. Advances in clinical chemistry. 115. 135–174. 1 indexed citations
12.
Ng, Beverly, Deepak R. Jadon, Frank Behrens, et al.. (2023). Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. 50(Suppl 2). 61–65. 1 indexed citations
13.
Siebert, Stefan, Stephen R. Pennington, S. P. Raychaudhuri, et al.. (2023). Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. 50(Suppl 2). 66–70.
14.
Coates, Laura C., Sreekumar Pillai, Hasan Tahir, et al.. (2021). Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study. Arthritis & Rheumatology. 73(9). 1663–1672. 16 indexed citations
15.
Coates, Laura C., Xenofon Baraliakos, Francisco J. Blanco, et al.. (2020). The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?. Arthritis Care & Research. 73(6). 856–860. 50 indexed citations
16.
17.
Chandran, Vinod, et al.. (2018). Nephroprotective Effect of Aqueous Extract of Pimpinella anisum in Gentamicin Induced Nephrotoxicity in Wistar Rats. Pharmacognosy Journal. 10(3). 403–407. 17 indexed citations
18.
Thavaneswaran, Arane, et al.. (2014). The effectiveness of leflunomide in psoriatic arthritis.. PubMed. 32(5). 728–31. 16 indexed citations
19.
Chandran, Vinod, et al.. (2011). Dyslipidemia with altered oxidant-antioxidant status in rheumatoid arthritis. International Journal of Pharma and Bio Sciences. 2(1). 424–428. 5 indexed citations
20.
Lucey, Simon, et al.. (2002). A theoretical framework for independent cassifier combination. Faculty of Built Environment and Engineering. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel O. Clegg Breakdown of academic impact, for papers by Eduardo Collantes‐Estévez Breakdown of academic impact, for papers by Masako Hara Breakdown of academic impact, for papers by Susanna Proudman Breakdown of academic impact, for papers by Ingiäld Hafström Breakdown of academic impact, for papers by Wayne Gulliver Breakdown of academic impact, for papers by Christina Ellervik Breakdown of academic impact, for papers by Vladimı́r Tesař Breakdown of academic impact, for papers by Marc A. Riedl Breakdown of academic impact, for papers by Sarfaraz Hasni
Rankless by CCL
2026